<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0017970"><a href="http://purl.obolibrary.org/obo/MONDO_0017970">MONDO:0017970</a></h3>
<p><strong>Label:</strong> 46,XY disorder of sex development due to impaired androgen production</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009384">MONDO:0009384</a> (leydig cell hypoplasia, type 1), <a href="http://purl.obolibrary.org/obo/MONDO_0020041">MONDO:0020041</a> (46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue), <a href="http://purl.obolibrary.org/obo/MONDO_0017971">MONDO:0017971</a> (46,XY disorder of sex development due to a cholesterol synthesis defect), <a href="http://purl.obolibrary.org/obo/MONDO_0019597">MONDO:0019597</a> (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0019595">MONDO:0019595</a> (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect), <a href="http://purl.obolibrary.org/obo/MONDO_0019155">MONDO:0019155</a> (leydig cell hypoplasia), <a href="http://purl.obolibrary.org/obo/MONDO_0019596">MONDO:0019596</a> (46,XY disorder of sex development due to testicular steroidogenesis defect), <a href="http://purl.obolibrary.org/obo/MONDO_0008730">MONDO:0008730</a> (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0019594">MONDO:0019594</a> (46,XY disorder of sex development due to a testosterone synthesis defect), <a href="http://purl.obolibrary.org/obo/MONDO_0018618">MONDO:0018618</a> (46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect), <a href="http://purl.obolibrary.org/obo/MONDO_0008725">MONDO:0008725</a> (congenital lipoid adrenal hyperplasia due to STAR deficency),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_201710">OMIM:201710</a>, <a href="http://www.orpha.net/ORDO/Orphanet_443090">Orphanet:443090</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98086">Orphanet:98086</a>, <a href="http://purl.obolibrary.org/obo/OMIM_202110">OMIM:202110</a>, <a href="http://www.orpha.net/ORDO/Orphanet_325511">Orphanet:325511</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90796">Orphanet:90796</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90786">Orphanet:90786</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90787">Orphanet:90787</a>, <a href="http://www.orpha.net/ORDO/Orphanet_418">Orphanet:418</a>, <a href="http://www.orpha.net/ORDO/Orphanet_96266">Orphanet:96266</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90790">Orphanet:90790</a>, <a href="http://www.orpha.net/ORDO/Orphanet_96265">Orphanet:96265</a>, <a href="http://www.orpha.net/ORDO/Orphanet_755">Orphanet:755</a>, <a href="http://purl.obolibrary.org/obo/OMIM_238320">OMIM:238320</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90793">Orphanet:90793</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90783">Orphanet:90783</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) and <a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0030338">HP:0030338</a> (Abnormal circulating gonadotropin level) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0011843">HP:0011843</a> (Abnormality of skeletal physiology) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0010514">HP:0010514</a> (Hyperpituitarism) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0008187">HP:0008187</a> (Absence of secondary sex characteristics) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0002750">HP:0002750</a> (Delayed skeletal maturation) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0000927">HP:0000927</a> (Abnormality of skeletal maturation) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0000837">HP:0000837</a> (Increased circulating gonadotropin level) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0000795">HP:0000795</a> (Abnormality of the urethra) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0000769">HP:0000769</a> (Abnormality of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0000062">HP:0000062</a> (Ambiguous genitalia) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000035">HP:0000035</a> (Abnormality of the testis) and <a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000028">HP:0000028</a> (Cryptorchidism) and <a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000037">HP:0000037</a> (Male pseudohermaphroditism) and <a href="http://purl.obolibrary.org/obo/HP_0010936">HP:0010936</a> (Abnormality of the lower urinary tract) and <a href="http://purl.obolibrary.org/obo/HP_0030349">HP:0030349</a> (Decreased circulating androgen level) and <a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology) 62.50%</li>
</ul>
</body>
</html>
